Deals
To acquaint you better with the varying transactions that we have advised our clients on over the past 25 years, we have attached "tombstone" listings of our representative transactions.
Recent Updates
- April 25, 2025
ReTo Eco-Solutions, Inc.
EGS represented ReTo Eco-Solutions, Inc. in its acquisition of 51% of the equity interests of MeinMalzeBier Holdings Limited, for aggregate consideration of
$19,890,000 - April 24, 2025
Texas Ventures Acquisition III Corp
EGS represented Texas Ventures Acquisition III Corp in its initial public offering in the amount of
$225,000,000 - April 23, 2025
Cantor Equity Partners, Inc.
EGS represented Cantor Equity Partners, Inc. in its definitive business combination agreement with Twenty One Capital, Inc., a Bitcoin-native company with a pro-forma enterprise value of
$3,600,000,000. - April 22, 2025
Aptevo Therapeutics Inc.
EGS represented Roth Capital Partners in Aptevo Therapeutics Inc.'s registered direct offering in the amount
$2,000,000 - April 21, 2025
NioCorp Developments Ltd.
EGS represented Maxim Group LLC in NioCorp Developments Ltd.'s underwritten public offering in the amount of
$20,000,000 - April 15, 2025
Can-Fite Biopharma Ltd.
EGS represented H.C. Wainwright & Co. in Can-Fite Biopharma Ltd.'s registered direct offering in the amount of
$3,000,000 - April 14, 2025
Venus Concept Inc.
EGS represented H.C. Wainwright & Co. in Venus Concept Inc.'s registered direct offering in the amount of
$1,500,000 - April 10, 2025
Immunic, Inc.
EGS represented Titan Partners Group in Immunic, Inc.'s registered direct offering in the amount of
$5,100,000 - April 10, 2025
Venus Concept Inc.
EGS represented H.C. Wainwright & Co. in Venus Concept Inc.'s registered direct offering in the amount of
$1,100,000 - April 7, 2025
NeuroOne Medical Technologies Corporation
EGS represented Ladenburg Thalmann & Co. Inc. in NeuroOne Medical Technologies Corporation's underwritten public offering in the amount of
$8,000,000 - April 7, 2025
Mobix Labs, Inc.
EGS represented Roth Capital Partners in Mobix Labs, Inc.'s registered direct offering in the amount of
$4,000,000 - April 4, 2025
Aptevo Therapeutics Inc.
EGS represented Roth Capital Partners in Aptevo Therapeutics Inc.'s registered direct offering and concurrent private placement in the amount of
$2,100,000
Browse the Deal Archive
Law Firm Rankings Our growth and successes led our Firm to achieve improved rankings among all U.S. law firms.
#1
in PIPEs/Registered Directs (agent's counsel)
#2
in the U.S. for most actively involved in IPOs of all law firms from 2017 to 2021
#1
SPAC Law Firm in the U.S. for SPAC IPOs and SPAC Acquisitions
$3 billion
raised through 20 SPAC IPOs in 2022